Latest Breaking News On - Uncontrolled hypertension - Page 6 : comparemela.com

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202

^Allschwil, Switzerland - June 23, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia's investigational dual endothelin receptor antagonist evaluating the treatment of patients with resistant hypertension, will be presented as an oral presentation by Prof. M.

Switzerland generalUnited statesAndrewc weissArthurc corcoranMarkus schlaichHypertension councilIdorsia pharmaceuticals ltdSwiss exchangeAmerican heart associationEuropean societyEuropean society of hypertensionIdorsia ltdEuropean society of cardiologyInternational society of hypertensionHead of investor relations corporate communicationsEuropean meeting

newratings de

newratings de
newratings.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newratings.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited statesIhre freundeAndrewc weissArthurc corcoranMarkus schlaichIdorsia ltdAmerican heart associationEuropean society of hypertensionSwiss exchangeInternational society of hypertensionEuropean society of cardiologyEuropean societyHypertension councilIdorsia pharmaceuticals ltdHead of investor relations corporate communications

Idorsia Pharmaceuticals Ltd: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2023

Idorsia Pharmaceuticals Ltd: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalArthurc corcoranMarkus schlaichAndrewc weissInternational society of hypertensionIdorsia pharmaceuticals ltdHead of investor relations corporate communicationsSwiss exchangeIdorsia ltdAmerican heart associationEuropean society of hypertensionHypertension councilEuropean society of cardiologyEuropean societyEuropean meeting

New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202

Allschwil, Switzerland – June 23, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia’s investigational dual endothelin receptor antagonist evaluating the

Switzerland generalUnited statesAndrewc weissArthurc corcoranMarkus schlaichIdorsia pharmaceuticals ltdHead of investor relations corporate communicationsSwiss exchangeInternational society of hypertensionHypertension councilEuropean society of cardiologyIdorsia ltdAmerican heart associationEuropean society of hypertensionEuropean societyEuropean meeting

New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2023

New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalAndrewc weissMarkus schlaichArthurc corcoranIdorsia pharmaceuticals ltdAmerican heart associationSwiss exchangeInternational society of hypertensionEuropean society of cardiologyEuropean society of hypertensionHypertension councilIdorsia ltdHead of investor relations corporate communicationsEuropean societyEuropean meeting